UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA

被引：265

作者：

INABA, M ^{[1
]}

JOHNSON, RK ^{[1
]}

机构：

[1] NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014

来源：

关键词：

D O I：

10.1016/0006-2952(78)90284-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2123 / 2130

页数：8

共 30 条

[1] CELLULAR PHARMACODYNAMICS OF SEVERAL ANTHRACYCLINE ANTIBIOTICS
BACHUR, NR
STEELE, M
MERIWETHER, WD
HILDEBRAND, RC
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (05) : 651 - 654
[2] MEMBRANE-MEDIATED DRUG-RESISTANCE AND PHENOTYPIC REVERSION TO NORMAL GROWTH-BEHAVIOR OF CHINESE-HAMSTER CELLS
BIEDLER, JL
RIEHM, H
PETERSON, RHF
SPENGLER, BA
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (03) : 671 - 680
[3] BIEDLER JL, 1970, CANCER RES, V30, P1184
[4] BLUM RH, 1975, CANCER CHEMOTH REP 3, V6, P247
[5] BONADONNA G, 1975, CANCER CHEMOTHER REP, V6, P321
[6] MECHANISM OF CELLULAR DRUG RESISTANCE
BOSMANN, HB
[J]. NATURE, 1971, 233 (5321) : 566 - &
[7] BOWEN D, 1975, CANCER RES, V35, P3054
[8] ADRIAMYCIN - REVIEW
CARTER, SK
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) : 1265 - 1274
[9] DANO K, 1972, CANCER RES, V32, P1307
[10] DANO K, 1972, CANCER CHEMOTH REP 1, V56, P321